论文信息 - Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study - 字舞流文

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study

X. Montalban | E. Radue | R. Gold | E. Havrdová | G. Giovannoni | K. Selmaj | T. Sprenger | Kimberly Umans | S. Greenberg | J. Elkins | S. Cohan | D. Stefoski | G. Ozen